icon-folder.gif   Conference Reports for NATAP  
 
  AASLD
The Liver Meeting
Boston MA
November 2016
Back grey_arrow_rt.gif
 
 
 
Distinct evolutionary pathways of NS5A inhibitor resistance in patients with genotype 1a versus 1b infection during monotherapy with MK-8742 (Elbasvir)
 
 
  Reported by Jules Levin
AASLD 2016 Nov 11-15 Boston, MA
 
Sara Williford, M.D., Shuntai Zhou, M.D., Christina Burch, Ph.D., Ernest Asante-Appiah, Ph.D., Anita Howe, Ph.D., Ronald Swanstrom, Ph.D., Stanley M. Lemon, M.D.
 
University of North Carolina at Chapel Hill Merck Research Laboratories

HCV1

HCV2

HCV3

HCV4

HCV5

HCV6

HCV7

HCV8